JP2023538326A5 - - Google Patents
Info
- Publication number
- JP2023538326A5 JP2023538326A5 JP2023509839A JP2023509839A JP2023538326A5 JP 2023538326 A5 JP2023538326 A5 JP 2023538326A5 JP 2023509839 A JP2023509839 A JP 2023509839A JP 2023509839 A JP2023509839 A JP 2023509839A JP 2023538326 A5 JP2023538326 A5 JP 2023538326A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- clathrate
- polymorph
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063064262P | 2020-08-11 | 2020-08-11 | |
| US63/064,262 | 2020-08-11 | ||
| PCT/US2021/045440 WO2022035898A1 (en) | 2020-08-11 | 2021-08-10 | Proteasome enhancers and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538326A JP2023538326A (ja) | 2023-09-07 |
| JP2023538326A5 true JP2023538326A5 (https=) | 2024-08-19 |
Family
ID=83103398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509839A Pending JP2023538326A (ja) | 2020-08-11 | 2021-08-10 | プロテアソームエンハンサ及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230295116A1 (https=) |
| EP (1) | EP4196119A4 (https=) |
| JP (1) | JP2023538326A (https=) |
| AU (1) | AU2021324684A1 (https=) |
| CA (1) | CA3191437A1 (https=) |
| MX (1) | MX2023001758A (https=) |
| WO (1) | WO2022035898A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025054147A1 (en) * | 2023-09-07 | 2025-03-13 | Cfd Research Corporation | Ph-responsive astemizole nanoparticles and methods for making and using the same |
| CN120118039B (zh) * | 2023-12-07 | 2025-11-28 | 南华大学 | 含芳基脲结构的苯并咪唑类衍生物、制造方法及其用途 |
| WO2025219559A1 (en) * | 2024-04-18 | 2025-10-23 | Booster Therapeutics Gmbh | Pyrrolidine compounds as proteasome stimulators |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4219559A (en) * | 1979-01-10 | 1980-08-26 | Janssen Pharmaceutica N.V. | N-Heterocyclyl-4-piperidinamines |
| ES555340A0 (es) * | 1985-06-18 | 1986-11-16 | Euroargenmex S A | Un nuevo procedimiento de preparacion de 2-(4-piperidilamino) benimidazoles |
| US5314903A (en) * | 1991-12-03 | 1994-05-24 | Neurosearch A/S | Benzimidazole compounds useful as calcium channel blockers |
| ES2222833B1 (es) * | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Compuestos piperidinicos 1,4-disustituidos, su preparacion y su uso como medicamentos. |
| WO2006038001A1 (en) * | 2004-10-06 | 2006-04-13 | Celltech R & D Limited | Aminopyrimidine derivatives as jnk inhibitors |
| GB0602335D0 (en) * | 2006-02-07 | 2006-03-15 | Remynd Nv | Thiadiazole Derivatives For The Treatment Of Neurodegenerative Diseases |
| TW200803855A (en) * | 2006-02-24 | 2008-01-16 | Kalypsys Inc | Quinolones useful as inducible nitric oxide synthase inhibitors |
| WO2008084218A1 (en) * | 2007-01-12 | 2008-07-17 | Boehringer Ingelheim International Gmbh | Benzazole derivatives for the treatment of inflammations |
| JP2010520876A (ja) * | 2007-03-09 | 2010-06-17 | アストラゼネカ・アクチエボラーグ | ピペラジンおよびピペリジンｍＧｌｕＲ５増強剤 |
| CA2693138A1 (en) * | 2007-07-16 | 2009-01-22 | Wyeth Llc | Aminoalkylazole derivatives as histamine-3 antagonists |
| WO2010010187A1 (en) * | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| JP5782234B2 (ja) * | 2010-06-16 | 2015-09-24 | チャイナ メディカル ユニヴァーシティーＣｈｉｎａ Ｍｅｄｉｃａｌ Ｕｎｉｖｅｒｓｉｔｙ | ベンゾイミダゾール化合物およびその使用 |
| WO2012020567A1 (en) * | 2010-08-09 | 2012-02-16 | Raqualia Pharma Inc. | Acyl piperazine derivatives as ttx-s blockers |
| KR101395146B1 (ko) * | 2011-02-09 | 2014-05-16 | 부산대학교 산학협력단 | 피부미백, 항산화 및 ｐｐａｒ 활성을 갖는 신규 화합물 및 이의 의학적 용도 |
| CA2829558A1 (en) * | 2011-03-09 | 2012-09-13 | Celgene Avilomics Research, Inc. | Pi3 kinase inhibitors and uses thereof |
| CN103044337A (zh) * | 2011-10-13 | 2013-04-17 | 南京理工大学 | 2-(n-烷基)氨基咪唑衍生物的合成方法 |
| AU2013216354B2 (en) * | 2012-02-02 | 2017-08-31 | Idorsia Pharmaceuticals Ltd | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
| EP2698367A1 (en) * | 2012-08-14 | 2014-02-19 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Benzimidazoles for the treatment of cancer |
| HUE039922T2 (hu) * | 2012-12-11 | 2019-02-28 | Takeda Pharmaceuticals Co | Heterociklusos vegyületek |
| KR101893879B1 (ko) * | 2017-03-31 | 2018-09-03 | 한국화학연구원 | 신규한 cdk 저해 화합물, 이의 제조방법, 및 이를 유효성분으로 함유하는 cdk 관련 질환의 예방 또는 치료용 약학적 조성물 |
| CN107556318B (zh) * | 2017-08-22 | 2020-08-11 | 山东大学 | 一种含哌啶的吡咯并嘧啶类化合物及其制备方法与应用 |
| CA3083000A1 (en) * | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| WO2019156991A1 (en) * | 2018-02-06 | 2019-08-15 | The Regents Of The University Of California | Methods of inhibiting formation of alpha synuclein aggregates |
| WO2020041100A1 (en) * | 2018-08-22 | 2020-02-27 | Merck Sharp & Dohme Corp. | Novel aryloxypiperidine pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors |
| CN110845423A (zh) * | 2019-12-06 | 2020-02-28 | 井冈山大学 | 一种1,2-取代苯并咪唑类化合物的制备方法 |
-
2021
- 2021-08-10 AU AU2021324684A patent/AU2021324684A1/en active Pending
- 2021-08-10 JP JP2023509839A patent/JP2023538326A/ja active Pending
- 2021-08-10 CA CA3191437A patent/CA3191437A1/en active Pending
- 2021-08-10 WO PCT/US2021/045440 patent/WO2022035898A1/en not_active Ceased
- 2021-08-10 EP EP21856599.2A patent/EP4196119A4/en active Pending
- 2021-08-10 MX MX2023001758A patent/MX2023001758A/es unknown
- 2021-08-10 US US18/041,179 patent/US20230295116A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538326A5 (https=) | ||
| JP6466348B2 (ja) | スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用 | |
| JP2024520481A5 (https=) | ||
| RU2010154130A (ru) | Соединения 5-замещенного изоиндолина | |
| JP2018158926A5 (https=) | ||
| JP2024529070A5 (https=) | ||
| CA2574600A1 (en) | Pyridine derivatives | |
| JP2024522174A5 (https=) | ||
| JP2022510925A5 (https=) | ||
| RU2017145650A (ru) | Ингибиторы тирозинкиназы брутона | |
| CA2458035A1 (en) | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | |
| JP2020535165A5 (https=) | ||
| JP2023552610A5 (https=) | ||
| JP2023533203A5 (https=) | ||
| JP2025509697A5 (https=) | ||
| JP2024518555A5 (https=) | ||
| JP2022534704A5 (https=) | ||
| JP2022538299A5 (https=) | ||
| JP2021512913A5 (https=) | ||
| JP2023518035A5 (https=) | ||
| JP2022533939A5 (https=) | ||
| JP2006509842A5 (https=) | ||
| JP2024522718A5 (https=) | ||
| JP2025502943A5 (https=) | ||
| RU2010113358A (ru) | Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов |